Methylprednisolone Sodium Succinate (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Methylprednisolone Sodium Succinate drug offered from Fresenius Kabi USA, LLC. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | METHYLPREDNISOLONE SODIUM SUCCINATE |
SUBSTANCE NAME: | METHYLPREDNISOLONE SODIUM SUCCINATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-11-30 |
END MARKETING DATE: | 0000-00-00 |
Methylprednisolone Sodium Succinate HUMAN PRESCRIPTION DRUG Details:
Item Description | Methylprednisolone Sodium Succinate from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/mL) |
START MARKETING DATE: | 2004-11-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-255_b90540a6-8490-45d8-b5ca-2d2cb7bf47b3 |
PRODUCT NDC: | 63323-255 |
APPLICATION NUMBER: | ANDA040583 |
Other METHYLPREDNISOLONE SODIUM SUCCINATE Pharmaceutical Manufacturers / Labelers: